This topic contains a solution. Click here to go to the answer

Author Question: The physician has requested that the respiratory therapist determine a patient's rapid shallow ... (Read 70 times)

craiczarry

  • Hero Member
  • *****
  • Posts: 527
The physician has requested that the respiratory therapist determine a patient's rapid shallow breathing index (RSBI) before placing the patient on PSV. The patient has a respiratory rate of 32/min and VT of 300 ml. What is the patient's RSBI?
 
  a. 107
  b. 110
  c. 112
  d. 114

Question 2

Which factors lead to the development of computer-based weaning protocols?
 
  1. Respiratory therapists are unable to successfully wean most patients using protocols.
  2. Computer-based weaning protocols are relatively easy to develop.
  3. Weaning is time-consuming.
  4. Weaning is a labor-intensive process.
  a. 3 only
  b. 1, 2, and 3 only
  c. 2, 3, and 4 only
  d. 1, 2, 3, and 4



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

briseldagonzales

  • Sr. Member
  • ****
  • Posts: 303
Answer to Question 1

ANS: A
The formula for calculating RSBI is f/VT. The therapist would calculate 32/0.30 = 107.

Answer to Question 2

ANS: C




craiczarry

  • Member
  • Posts: 527
Reply 2 on: Jul 16, 2018
Excellent


  • Member
  • Posts:
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library